Patient and Healthcare Provider Perspectives on Disease Burden of Seborrheic Dermatitis in the United States: Results from a National Survey.
Disease burden
Healthcare provider-reported outcomes
Patient-reported outcomes
Seborrheic dermatitis
Journal
Dermatology and therapy
ISSN: 2193-8210
Titre abrégé: Dermatol Ther (Heidelb)
Pays: Switzerland
ID NLM: 101590450
Informations de publication
Date de publication:
28 Oct 2024
28 Oct 2024
Historique:
received:
29
08
2024
accepted:
27
09
2024
medline:
28
10
2024
pubmed:
28
10
2024
entrez:
28
10
2024
Statut:
aheadofprint
Résumé
Seborrheic dermatitis (SD) is a common, chronic inflammatory skin disease, but the physical and emotional burden of patients with SD experience has not been well characterized. The Harris Poll conducted online surveys of US patients and healthcare providers (HCPs) from December 2021 to January 2022. Almost half of patients reported that SD negatively impacts their emotional and physical well-being "a lot/a great deal"; HCPs underestimate the level of impact on patients. Most patients with SD reported a significant mental health impact, including anxiety, depression, anxiety about interacting with other people, and isolation. Two-thirds of patients said they did not know anyone else who had been diagnosed with SD, and even after diagnosis, less than half of patients still said they did not know anyone else with SD. Nearly all patients and HCPs agreed that it was challenging to hide SD symptoms, and most patients felt embarrassed when people commented on their SD symptoms. Most patients agreed that they would be further along in their career if they did not have SD, and SD symptoms made them less confident at work and less likely to want to interact with people at work. Almost half of patients reported ever missing work as a result of SD symptoms. These insights emphasize the physical and emotional patient burden associated with SD, impacting all aspects of patients' lives. Graphical abstract available for this article.
Identifiants
pubmed: 39466365
doi: 10.1007/s13555-024-01288-9
pii: 10.1007/s13555-024-01288-9
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
© 2024. The Author(s).
Références
Wikramanayake TC, Borda LJ, Miteva M, Paus R. Seborrheic dermatitis—Looking beyond Malassezia. Exp Dermatol. 2019;28(9):991–1001.
doi: 10.1111/exd.14006
pubmed: 31310695
Berk T, Scheinfeld N. Seborrheic dermatitis. P T. 2010;35(6):348–52.
pubmed: 20592880
pmcid: 2888552
Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Investig Dermatol. 2015;3(2). https://doi.org/10.13188/2373-1044.1000019 .
Cheong WK, Yeung CK, Torsekar RG, et al. Treatment of seborrhoeic dermatitis in Asia: a consensus guide. Skin Appendage Disord. 2016;1(4):187–96.
doi: 10.1159/000444682
pubmed: 27386464
pmcid: 4908450
Davis SA, Narahari S, Feldman SR, Huang W, Pichardo-Geisinger RO, McMichael AJ. Top dermatologic conditions in patients of color: an analysis of nationally representative data. J Drugs Dermatol. 2012;11(4):466–73.
pubmed: 22453583
Elgash M, Dlova N, Ogunleye T, Taylor SC. Seborrheic dermatitis in skin of color: clinical considerations. J Drugs Dermatol. 2019;18(1):24–7.
pubmed: 30681789
Buja A, Miatton A, Cozzolino C, et al. The global, regional, and national burden of seborrheic dermatitis: results and insights from the Global Burden of Disease 2019 Study. Arch Dermatol Res. 2023;315(5):1143–9.
pubmed: 36445473
Andersen YMF, Egeberg A. Seborrhoeic dermatitis – understood or understudied? Br J Dermatol. 2019;181(4):659.
doi: 10.1111/bjd.18307
pubmed: 31361331
Karimkhani C, Dellavalle RP, Coffeng LE, et al. Global skin disease morbidity and mortality: an update from the Global Burden of Disease Study 2013. JAMA Dermatol. 2017;153(5):406–12.
doi: 10.1001/jamadermatol.2016.5538
pubmed: 28249066
pmcid: 5817488
Xue Y, Bao W, Zhou J, et al. Global burden, incidence and disability-adjusted life-years for dermatitis: a systematic analysis combined with socioeconomic development status, 1990–2019. Front Cell Infect Microbiol. 2022;12: 861053.
doi: 10.3389/fcimb.2022.861053
pubmed: 35493737
pmcid: 9039287
Araya M, Kulthanan K, Jiamton S. Clinical characteristics and quality of life of seborrheic dermatitis patients in a tropical country. Indian J Dermatol. 2015;60(5):519.
doi: 10.4103/0019-5154.164410
pubmed: 26538714
pmcid: 4601435
Szepietowski JC, Reich A, Wesolowska-Szepietowska E, Baran E, National Quality of Life in Dermatology Group. Quality of life in patients suffering from seborrheic dermatitis: influence of age, gender and education level. Mycoses. 2009;52(4):357–63.
Cömert A, Akbas B, Kilic EZ, et al. Psychiatric comorbidities and alexithymia in patients with seborrheic dermatitis: a questionnaire study in Turkey. Am J Clin Dermatol. 2013;14(4):335–42.
doi: 10.1007/s40257-013-0019-7
pubmed: 23609607
Pärna E, Aluoja A, Kingo K. Quality of life and emotional state in chronic skin disease. Acta Derm Venereol. 2015;95(3):312–6.
doi: 10.2340/00015555-1920
pubmed: 24978135
Chernyshov PV, Vozianova SV, Chubar OV. Quality of life of infants, toddlers and preschoolers with seborrhoeic, allergic contact and atopic dermatitis before and during COVID-19 pandemic. Dermatol Ther (Heidelb). 2021;11(6):2017–26.
doi: 10.1007/s13555-021-00617-6
pubmed: 34562266
Xuan M, Lu C, He Z. Clinical characteristics and quality of life in seborrheic dermatitis patients: a cross-sectional study in China. Health Qual Life Outcomes. 2020;18:308.
doi: 10.1186/s12955-020-01558-y
pubmed: 32938485
pmcid: 7493366
Wei W, Anderson P, Gadkari A, et al. Discordance between physician- and patient-reported disease severity in adults with atopic dermatitis: a US cross-sectional survey. Am J Clin Dermatol. 2017;18(6):825–35.
doi: 10.1007/s40257-017-0284-y
pubmed: 28447213
pmcid: 5680372
Carr E, Mahil SK, Brailean A, et al. Association of patient mental health status with the level of agreement between patient and physician ratings of psoriasis severity. JAMA Dermatol. 2021;157(4):413–20.
doi: 10.1001/jamadermatol.2020.5844
pubmed: 33656512
Bacon RA, Mizoguchi H, Schwartz JR. Assessing therapeutic effectiveness of scalp treatments for dandruff and seborrheic dermatitis, part 1: a reliable and relevant method based on the Adherent Scalp Flaking Score (ASFS). J Dermatolog Treat. 2014;25(3):232–6.
doi: 10.3109/09546634.2012.687089
pubmed: 22515728
Baysal V, Yildirim M, Ozcanli C, Ceyhan AM. Itraconazole in the treatment of seborrheic dermatitis: a new treatment modality. Int J Dermatol. 2004;43(1):63–6.
doi: 10.1111/j.1365-4632.2004.02123.x
pubmed: 14693026
Parasramani SG, Vishwanath V, Ghia D, Gandhi MR, Dhoot D, Barkate H. Prospective, open-label, multi-centre, randomized study to compare the effectiveness, safety, and tolerability of Lulican™ shampoo versus ketoconazole shampoo in Indian adult patients with mild to moderate scalp seborrheic dermatitis (LEAD study). Cureus. 2022;14(11):e32035.
pubmed: 36600812
pmcid: 9801137
Piérard-Franchimont C, Quatresooz P, Piérard GE. Specular light reflectance of flakes in seborrhoeic dermatitis of the scalp: a pilot study. Clin Exp Dermatol. 2011;36(7):793–6.
doi: 10.1111/j.1365-2230.2011.04120.x
pubmed: 21689149
Zhang F, Li Y, Ren W, Li S. Establishment of clinical evaluation criteria for scalp seborrheic dermatitis. J Cosmet Dermatol. 2023;22(11):3042–6.
doi: 10.1111/jocd.15804
pubmed: 37170659
Hollins LC, Butt M, Hong J, Taylor SC. Research in brief: survey of hair care practices in various ethnic and racial pediatric populations. Pediatr Dermatol. 2022;39(3):494–6.
doi: 10.1111/pde.14958
pubmed: 35243692
Rucker Wright D, Gathers R, Kapke A, Johnson D, Joseph CLM. Hair care practices and their association with scalp and hair disorders in African American girls. J Am Acad Dermatol. 2011;64(2):253–62.
doi: 10.1016/j.jaad.2010.05.037
pubmed: 20728245
Zeidler C, Kupfer J, Dalgard FJ, et al. Dermatological patients with itch report more stress, stigmatization experience, anxiety and depression compared to patients without itch: results from a European multi-centre study. J Eur Acad Dermatol Venereol. 2024;38(8):1649–61.
doi: 10.1111/jdv.19913
pubmed: 38468596
Ozcan Y, Sungur MA, Ozcan BY, Eyup Y, Ozlu E. The psychosocial impact of chronic facial dermatoses in adults. Dermatol Pract Concept. 2023;13(1):e2023029.
doi: 10.5826/dpc.1301a29
pubmed: 36892338
pmcid: 9946076
Güder H, Güder S, Taşlidere N. Social media usage habits and treatment-seeking of patients with seborrheic dermatitis: a cross-sectional study. Türkiye Klinikleri Dermatoloji Dergisi. 2022;32(3):151–6.
doi: 10.5336/dermato.2022-90363
Fakhraie S, Erickson T, Chovatiya R. Evaluation of a patient education platform for seborrheic dermatitis. Arch Dermatol Res. 2023;315(10):2927–30.
doi: 10.1007/s00403-023-02681-8
pubmed: 37500910
Wolf JA, Moreau JF, Patton TJ, Winger DG, Ferris LK. Prevalence and impact of health-related internet and smartphone use among dermatology patients. Cutis. 2015;95(6):323–8.
pubmed: 26125208
Saxena A, Dey V, Srivastava P, Hemnani S, Kushwaha S, Sharma S. Treatment-seeking behavior of patients attending department of dermatology in a tertiary care hospital and their impact on disease. Medical Journal of Dr D Y Patil Vidyapeeth. 2023;16(2):167–72.
doi: 10.4103/mjdrdypu.mjdrdypu_123_21
Baş Y, Seckin HY, Kalkan G, et al. Prevalence and related factors of psoriasis and seborrheic dermatitis: a community-based study. Turk J Med Sci. 2016;46(2):303–9.
doi: 10.3906/sag-1406-51
pubmed: 27511489
Etgu F. Analysis of the epidemiology, coexisting skin diseases, and variables affecting seborrheic dermatitis severity. Med Sci Int Med J. 2023;12(4):994–7.
doi: 10.5455/medscience.2023.08.120
Sarac E, Kocatürk E. Relationship between disease severity, perceived stress, and depression in patients with seborrheic dermatitis. Marmara Med J. 2022;35(3):362–6.
doi: 10.5472/marumj.1195298
Goyal N, Prabhu SS. Stress and common dermatological disorders: the psychophysiological dermatoses. Clin Dermatol Rev. 2023;7(4):327–32.
doi: 10.4103/cdr.cdr_8_22
Lancar R, Missy P, Dupuy A, et al. Risk factors for seborrhoeic dermatitis flares: case-control and case-crossover study. Acta Derm Venereol. 2020;100(17):adv00292.
Andersen L, Nyeland ME, Nyberg F. Increasing severity of atopic dermatitis is associated with a negative impact on work productivity among adults with atopic dermatitis in France, Germany, the U.K. and the U.S.A. Br J Dermatol. 2020;182(4):1007–16.
Drucker AM, Wang AR, Li W-Q, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: summary of a report for the National Eczema Association. J Invest Dermatol. 2017;137(1):26–30.
doi: 10.1016/j.jid.2016.07.012
pubmed: 27616422
Bickers DR, Lim HW, Margolis D, et al. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol. 2006;55(3):490–500.
doi: 10.1016/j.jaad.2006.05.048
pubmed: 16908356
Peyrí J, Lleonart M, Grupo español del Estudio SEBDERM. Clinical and therapeutic profile and quality of life of patients with seborrheic dermatitis. Article in Spanish. Actas Dermosifiliogr. 2007;98(7):476–82.
Wang J, Zhang Y, Li B, et al. Eczema, facial erythema, and seborrheic dermatitis symptoms among young adults in China in relation to ambient air pollution, climate, and home environment. Indoor Air. 2022;32(1):e12918.
doi: 10.1111/ina.12918
pubmed: 34337784